Company Equasens

Equities

EQS

FR0012882389

IT Services & Consulting

Market Closed - Euronext Paris 11:35:24 2024-05-31 am EDT 5-day change 1st Jan Change
61.6 EUR -1.75% Intraday chart for Equasens -1.75% +0.82%

Business Summary

Equasens is No. 1 in France for publishing and integrating software programs for pharmacies, hospitals, healthcare facilities, laboratories, retirement homes and healthcare professionals. Net sales break down by activity as follows:

- pharmacy software publishing and integration (74%): software programs for managing data bases, information, inventories, orders, electronic care records, etc.;

- publishing of IT solutions for health and medical/social establishments (14.2%): publishing and integration of software packages for retirement homes, hospitals and care homes (software for managing admissions, billing, receipt and accounting management, care management, supply management, etc.);

- development of solutions and infrastructures for e-Health (11.8%): digital communication, telemedicine and telehealth solutions. The group also offers financing solutions for leased goods (Nanceo).

Net sales are distributed geographically as follows: France (89.7%), Italy (5.4%), Belgium (2.9%), Germany (1%), the United Kingdom (0.8%) and Ireland (0.2%).

Sales per Business

EUR in Million2022Weight2023Weight Delta
Pharmagest
74.0 %
156 73.0 % 163 74.0 % +4.11%
Axigate Link
14.2 %
33 15.2 % 31 14.2 % -4.56%
Others
11.8 %
25 11.8 % 26 11.8 % +3.09%

Sales per region

EUR in Million2022Weight2023Weight Delta
France
89.7 %
194 90.9 % 197 89.7 % +1.37%
Italy
5.4 %
10 4.9 % 12 5.4 % +14.14%
Belgium
2.9 %
6 2.6 % 6 2.9 % +13.52%
Germany
1.0 %
2 0.8 % 2 1.0 % +33.97%
United Kingdom
0.8 %
2 0.7 % 2 0.8 % +8.48%
Ireland
0.2 %
0 0.1 % 0 0.2 % +61.73%
Luxembourg
0.0 %
0 0.0 % 0 0.0 % -41.98%

Managers

Managers TitleAgeSince
Chief Executive Officer 55 90-12-31
Founder 65 96-01-24
Director of Finance/CFO - 22-12-31
Chief Tech/Sci/R&D Officer - 18-06-30
Director/Board Member 53 20-06-28
Director/Board Member 59 99-12-31
Human Resources Officer - 18-12-31
Corporate Officer/Principal - -
Corporate Officer/Principal - -
Corporate Officer/Principal 50 05-12-31

Members of the board

Members of the board TitleAgeSince
Founder 65 96-01-24
Director/Board Member 46 17-06-26
Director/Board Member 59 99-12-31
Director/Board Member 72 01-12-31
Director/Board Member 55 11-06-15
Chief Executive Officer 55 90-12-31
Director/Board Member 60 22-05-31
Director/Board Member 65 10-12-31
Director/Board Member 67 12-06-21
Director/Board Member 45 17-06-26

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 15,174,125 4,919,380 ( 32.42 %) 142,890 ( 0.9417 %) 32.42 %

Shareholders

NameEquities%Valuation
La Cooperative Welcoop SA
66.64 %
10,111,855 66.64 % 637 M €
Amundi Asset Management SA (Investment Management)
1.952 %
296,168 1.952 % 19 M €
DNCA Finance SA
1.430 %
217,057 1.430 % 14 M €
Crédit Mutuel Asset Management SA
0.9417 %
142,900 0.9417 % 9 M €
EQUASENS
0.9386 %
142,428 0.9386 % 9 M €
Danske Bank A/S (Investment Management)
0.9093 %
137,974 0.9093 % 9 M €
Amplegest SAS
0.8735 %
132,540 0.8735 % 8 M €
Gay-Lussac Gestion SA
0.6542 %
99,262 0.6542 % 6 M €
Capricorn Venture Partners NV (Investment Management)
0.5887 %
89,330 0.5887 % 6 M €
Joh. Berenberg, Gossler & Co. KG (Investment Management)
0.3750 %
56,900 0.3750 % 4 M €

Holdings

NameEquities%Valuation
142,428 0.94% 8,969,949 $

Company contact information

Equasens

5, Allée de Saint-Cloud Technopole de Nancy Brabois

54600, Villers-lès-Nancy

+33 3 83 15 95 95

http://equasens.com
address Equasens(EQS)

Sales per Business

Sales per region

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
61.6 EUR
Average target price
70.07 EUR
Spread / Average Target
+13.74%
Consensus

Quarterly revenue - Rate of surprise